Federal Register Watch: November 9, 2026

Flat editorial illustration in muted navy, burgundy, beige, and institutional gray. A towering stack of thick government documents and rule books sits on a government desk, with small bureaucratic figures in suits examining pages with magnifying glasses. A large calendar on the wall reads "November 9." The scene has a dry, deadpan newspaper illustration style — no bright colors, no whimsy, just the quiet weight of federal paperwork.

The Centers for Medicare & Medicaid Services used today’s Federal Register to finalize two of the year’s biggest Medicare rules at once, setting 2027 physician payment rates while locking in the mechanics of the drug-price negotiation program required by the Inflation Reduction Act. Elsewhere, the Commerce Department quietly pushed back an export-control deadline for the second time, Treasury let a six-year-old anti-money-laundering proposal simply disappear, and a civil-rights records board disclosed a decision it had already made behind closed doors.

  • Centers for Medicare & Medicaid Services finalized the calendar-year 2027 Physician Fee Schedule, the single largest document in today’s issue, cutting overall physician payment rates while launching a mandatory new payment model that holds specialists accountable for the cost and quality of heart-failure and low-back-pain care. The rule also closes what CMS calls a billing “windfall” loophole it estimates will avoid $2.38 billion in incentive overpayments over the next decade, and starts a multi-year sunset of the traditional MIPS quality-reporting track in favor of newer alternative payment models. Because this one rule sets the base rates Medicare pays for nearly every outpatient physician visit nationwide, even a small change to its underlying formula ripples through every physician practice and, eventually, into what beneficiaries owe in cost-sharing. It takes effect January 1, 2027. (Federal Register)
  • In the same batch, CMS also finalized policy for the Medicare Drug Price Negotiation Program and Part D, codifying how the negotiated drug prices required by the Inflation Reduction Act will interact with Part D benefit design starting with initial price applicability year 2029. The rule itself becomes effective December 5, 2026, years before patients see a negotiated price at the pharmacy counter, a reminder that the technical scaffolding for major health-policy changes is usually built out quietly, well ahead of any public-facing effect. Because the negotiation program remains one of the more politically contested pieces of the IRA, how CMS writes these implementing details can end up mattering as much as the headline prices themselves. (Federal Register)
  • The Bureau of Industry and Security extended, for a second time, its suspension of the so-called affiliates rule, which would expand export controls to cover companies affiliated with entities on BIS’s restricted-party lists. The rule was originally paused for a year in November 2025 as part of the U.S.-China trade truce; rather than letting that one-year suspension run its course or converting it into a settled policy, BIS has now pushed the effective date back again, to January 10, 2027, just two months past the original deadline. A short, incremental extension rather than a clean renewal is the kind of detail that suggests the underlying trade diplomacy is still unsettled, since exporters have to keep planning around a control regime that could snap back into force on short notice. (Federal Register)
  • The Treasury Department’s Financial Crimes Enforcement Network, together with the Federal Reserve Board, withdrew a six-year-old proposal that would have lowered the Bank Secrecy Act recordkeeping threshold for international funds transfers from $3,000 to $250 and extended it explicitly to cover convertible virtual currency and other digital-asset transactions. A lower threshold would have forced banks to collect and retain sender and recipient information on many more cross-border transfers, including small ones; anti-money-laundering advocates had argued this closed a gap exploited by illicit finance, while banks warned it would sweep in ordinary remittances. Letting a long-pending AML tightening proposal lapse entirely, rather than finalizing or narrowing it, is itself a policy choice worth noting given how much attention digital-asset compliance rules have drawn in recent years. (Federal Register)
  • The Office of Personnel Management proposed renaming and restructuring the Privacy Act system of records behind the governmentwide Federal Employee Viewpoint Survey, rebranding it the “Annual Employee Survey” and shifting it from one centralized OPM-run survey to each executive agency administering its own, sending only de-identified results back to OPM and the Office of Management and Budget. Decentralizing a survey that has, for two decades, given Congress, researchers and watchdog groups a single consistent dataset on federal workforce morale makes it harder to compare agencies on equal footing or track trends over time, since the underlying individual-level records will no longer sit in one place. Comments are due December 9, 2026, a 30-day window that gives unions and former OPM officials a narrow chance to weigh in before the new structure takes effect the following day. (Federal Register)
  • The Civil Rights Cold Case Records Review Board disclosed that it had already decided, at an October 23 closed session, how to handle 11,428 pages and one video of records tied to two cold civil-rights cases, approving the government’s request to keep 1,772 pages sealed while ordering 9,696 pages released in full. For one of the two incidents, the Board will now ask the Attorney General to petition a federal court to unseal grand jury material, a step required because grand jury secrecy is one of the few categories of government information that even a presidentially appointed declassification board cannot simply order opened on its own. Publishing the outcome of a decision already made, rather than soliciting input beforehand, is standard practice for this board, but it’s a reminder that the public sees only the result of a process it had no part in. (Federal Register)

This edition reviewed all 98 documents published in the November 9, 2026 Federal Register (Volume 91, Number 215, pages 70769–72390). Excluded as routine: meeting and Sunshine Act notices, antidumping/countervailing-duty administrative determinations, SEC self-regulatory-organization rule filings, Paperwork Reduction Act information-collection notices, FAA airworthiness directives and other individual aircraft/airspace actions, hazardous-materials permit notices, and other recurring procedural filings that did not raise an institutional or anomaly signal.

Fediverse reactions

Advertisements

Discover more from Bureaucracy Times

Subscribe to get the latest posts sent to your email.